Free Trial

Audinate Group (AUDGF) News Today

$10.13
0.00 (0.00%)
(As of 07/5/2024 ET)
Get Audinate Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AUDGF and its competitors with MarketBeat's FREE daily newsletter.

NYSE biotech company's drug could be as revolutionary as penicillin! (Ad)

NV-387 could be a single drug to treat all of the "tripledemic" viruses and more! See how NV-387 could be highly valuable for preparedness against novel viral epidemics and pandemics all while building shareholder value for this growing biotech company

Click here for the company ticker

AUDGF Media Mentions By Week

AUDGF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AUDGF
News Sentiment

0.67

0.83

Average
Computer and Technology
News Sentiment

AUDGF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AUDGF Articles
This Week

0

0

AUDGF Articles
Average Week

Get Audinate Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AUDGF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:AUDGF) was last updated on 7/8/2024 by MarketBeat.com Staff

From Our Partners